Wastewater SCAN data show that human metapneumovirus, or HMPV, is rampant in Northern California—specifically San Francisco, Marin, Vallejo, Napa, Novato, Santa Rosa, Sacramento and Davis, per reports.
Public health officials and wastewater surveillance networks are reporting a significant surge in human metapneumovirus, or HMPV, across Northern California and several other regions in the United States. Data from Wastewater SCAN and the Centers for Disease Control and Prevention indicate that while the virus peaked in January, levels remain elevated through early March. The uptick in detections has prompted medical experts to warn of the risks associated with this lesser-known but highly contagious respiratory pathogen.
The current outbreak is particularly concentrated in Northern California municipalities including San Francisco, Sacramento, Santa Rosa, and Napa. However, the geographic footprint of the virus is expanding beyond the West Coast. According to Dr. Marc Siegel, a senior medical analyst, the virus is a single-stranded RNA virus, like flu and COVID, and the virus is increasing not only in the west, but also around the country.
Data from the National Wastewater Surveillance System (NWSS), a division of the CDC, confirms that HMPV concentrations are also rising sharply in the Midwest and Northeast. This comprehensive monitoring of sewage samples allows health officials to detect infection patterns in communities before they manifest in clinical testing. The current data suggest that while the traditional winter seasonal wave is beginning to taper, the viral load in the environment remains a concern for public health.
Human metapneumovirus belongs to the same viral family as respiratory syncytial virus, commonly known as RSV. Despite its current prevalence, HMPV is a relatively recent discovery in the field of virology, having been first identified by researchers in 2001. Since its discovery, it has been recognized as a leading cause of upper and lower respiratory tract infections, often circulating alongside more prominent seasonal illnesses.
The symptoms of HMPV frequently mimic those of the common cold, influenza, or COVID-19, which often leads to under-diagnosis in the general population. According to the CDC, the most common symptoms of the virus in healthy children and adults include cough, fever, nasal congestion and shortness of breath. Because there is currently no specific antiviral treatment or vaccine available for HMPV, medical management is primarily limited to supportive care and symptom relief.
While many cases remain mild, the virus poses a significant threat to vulnerable populations. Those at the highest risk of severe illness, such as pneumonia, include young children, older adults and those who are immunocompromised. Clinical data suggest that HMPV is responsible for a substantial burden on healthcare systems globally. It leads to over 650,000 hospitalizations yearly worldwide, according to Siegel.
In pediatric cases, the virus can lead to more serious complications beyond standard respiratory distress. Rare effects of HMPV can include asthma attacks, wheezing, difficulty breathing, bronchiolitis, ear infections, croup, and fever, according to the CDC. Bronchiolitis, an infection of the small airways, is of particular concern for infants and toddlers whose respiratory systems are still developing.
For the elderly and those with underlying health issues, HMPV can trigger life-threatening exacerbations of existing conditions. Adults with chronic obstructive pulmonary disease (COPD) are especially susceptible to complications if they contract the virus. Dr. Siegel confirmed the severity of these interactions, noting that the virus can worsen chronic lung conditions. This often results in prolonged hospital stays and a requirement for supplemental oxygen or mechanical ventilation.
The rise of HMPV underscores the evolving nature of respiratory disease surveillance in the post-pandemic era. During the height of the COVID-19 pandemic, many common respiratory viruses saw a decline in transmission due to social distancing and masking. As these behaviors have shifted, viruses like HMPV and RSV have returned with altered seasonality and increased intensity. The use of wastewater monitoring has become a critical tool in tracking these shifts in real-time.
Historically, HMPV has been overshadowed by the “big three” of respiratory illness: COVID-19, influenza, and RSV. However, the economic and social impact of HMPV is becoming increasingly clear to policymakers. The lack of a rapid diagnostic test commonly available in primary care settings means many patients do not know they have the virus, potentially leading to the inappropriate prescription of antibiotics for what is a viral infection.
The transmission of HMPV occurs through typical respiratory routes, including secretions from coughing and sneezing, close personal contact, and touching contaminated surfaces. Health officials emphasize that standard hygiene practices remain the most effective defense against the spread. Frequent handwashing, disinfecting shared surfaces, and staying home when symptomatic are recommended to curb the current regional spikes.
In the broader context of global health, HMPV represents a persistent challenge for vaccine development. Because it is a paramyxovirus, it shares structural similarities with RSV, which only recently saw the approval of its first vaccines for older adults and infants. Research into an HMPV vaccine is ongoing, but clinical trials have yet to produce a commercially available preventative measure. Until such a breakthrough occurs, public health relies on surveillance and hospital capacity management.
Regional health departments in Northern California are continuing to monitor the situation closely as the spring season approaches. While the tapering of the winter wave provides some relief, the “elevated” status of the virus in early March suggests that the tail of the outbreak could persist for several weeks. Residents in affected areas, particularly those in the Sacramento and San Francisco Bay Area corridors, are advised to remain vigilant regarding respiratory health.
The emergence of these data points from the NWSS highlights the growing importance of environmental virology. By tracking the presence of HMPV in municipal wastewater, officials can provide early warnings to hospitals to prepare for an influx of patients with pneumonia or bronchiolitis. This proactive approach is seen as essential for managing the seasonal surges that now characterize the American respiratory landscape.
As the Midwest and Northeast begin to see similar sharp increases in HMPV detection, the national health community is bracing for a potential late-season surge in these regions. The patterns observed in California often serve as a bellwether for trends that eventually move across the continental United States. Consequently, the Northern California data are being scrutinized by epidemiologists to predict the duration and severity of the outbreaks currently forming in the eastern half of the country.
In summary, human metapneumovirus has established itself as a significant public health threat that requires greater public awareness. With hundreds of thousands of annual hospitalizations and a lack of specific medical interventions, the virus remains a primary concern for the elderly and the young. As wastewater levels remain high, the medical community continues to advocate for increased testing and a greater emphasis on preventative hygiene to protect those most at risk for severe complications.
